News & insights
Pfizer
Articles from Apotek Analytics.
-

US loses measles elimination status while Isomorphic raises record $5bn
Global health authorities said the United States has lost its measles elimination status after several states faced their worst outbreaks in nearly three decades, and the CDC and partners set out plans to stop the outbreaks and restore it.
-

GLP-1 Drugs may risk investments in other essential treatments
Diabetes care in poorer settings drew attention from two directions.
-

FDA tentatively approves first generic lenacapavir. Zolgensma tumour cases shake gene therapy
HIV prevention moved closer to reach in poorer countries as the FDA gave tentative approval to the first generic lenacapavir.
-

Pfizer, Roche and AstraZeneca lead a week of drug discovery deals
Pfizer, Roche and AstraZeneca each struck discovery deals reported at $500m or more, as regulators in the UK, US and Europe signalled changes in how they weigh evidence.